| Octapharma AG - octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung |
| 69780 | | 01 | | octaplasLG | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | | B05AA | | Blood Substitutes and Plasma Protein Fractions | | 12.11.2024 | | |
|
| Composition |
| Praeparatio cryodesiccata: proteina plasmatis humani 9-14 g, natrii citras dihydricus, natrii dihydrogenophosphas dihydricus, acidum citricum monohydricum, acidum phosphoricum, glycinum, pro vitro corresp. natrium <40 mmol.
Solvens: aqua ad iniectabile pro charta. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Pulver und Lösungsmittel zur Herstellung einer Infusionslösung | | | | | | Active Agent | Dose |
|---|
| Proteina Plasmatis Humani | 9-14 g |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Phosphoric Acid | | Glycin | | Natrii Citras Dihydricus | | Sodium Dihydrogenophosphate Dihydrate |
|
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
| Solvens | | aqua ad iniectabile pro charta | | | |
|
|
